Skip to main content
Lindsay Wilde, MD, Oncology, Philadelphia, PA, Thomas Jefferson University Hospital

LindsayReneeWildeMD

Oncology Philadelphia, PA

Hematologic Oncology

Assistant Professor

Dr. Wilde is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wilde's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2015 - 2018
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHChief Residency, Internal Medicine, 2014 - 2015
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2011 - 2014
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 2011 - 2012
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2011

Certifications & Licensure

  • DE State Medical License
    DE State Medical License 2019 - 2025
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • PA State Medical License
    PA State Medical License 2011 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society, 2011

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid Leukemia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Authored Content

  • SOHO 2021: TP53 Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia Remain a Therapeutic ChallengeSeptember 2021

Press Mentions

  • How to Discuss Cancer Prognosis with Patients & Family
    How to Discuss Cancer Prognosis with Patients & FamilySeptember 5th, 2019

Professional Memberships

Hospital Affiliations